Imcyse is a biopharmaceutical company that develops and commercializes immunotherapies for the treatment of chronic autoimmune diseases.
Business Model:
Revenue: $4M
Employees: 11-50
Address: Avenue Pré-Aily 14
City: Liege
State: liège
Zip: 4031
Country: BE
Imcyse is a biopharmaceutical company that develops and commercializes immunotherapies for the treatment of chronic autoimmune diseases.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 2/2021 | Series B | $25.8M |
Biogenesis Ventures Epimede LSP Noshaq Societe Regionale d'Investissement de Wallonie Societe Federale de Participations et d'Investissement KU Leuven Pfizer Inc |
6/2019 | Debt Financing | $0 |
Belfius Bank Belfius Bank |
2/2021 | Series B | 7 | $25.7M |
Biogenosis Epimède SA Meusinvest (Noshaq) Pfizer S.R.I.W. SFPI-FPIM University of Leuven Biogenosis Epimède SA Meusinvest (Noshaq) Pfizer S.R.I.W. SFPI-FPIM University of Leuven |
6/2019 | Grant | 1 | $5.2M |
W.IN.G W.IN.G |
6/2019 | Series B | 4 | $31.4M |
LSP BioVentures Meusinvest (Noshaq) S.R.I.W. SFPI-FPIM LSP BioVentures Meusinvest (Noshaq) S.R.I.W. SFPI-FPIM |
6/2019 | Series B | $39.5M |
Life Sciences Partners Epimède Societe Regionale dŠ—ÈInvestissement de Wallonie Société Fédérale de Participations et d’Investissement Noshaq Biogenesis Ventures University of Leuven Belfius |
6/2019 | Debt Financing | 1 | $2.2M |
Belfius Bank Belfius Bank |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|